ScholarIQanswers from OpenAlex

Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression

PaperCitations, authors & open-access status

Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression have?

ScholarIQcitation count

Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression has 26 citations in the OpenAlex counts ScholarIQ stores.

When was Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression published?

ScholarIQyear

Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression has 2022 year in the ScholarIQ index.

What is the open-access status of Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression?

ScholarIQoa status

Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression has gold oa status in the ScholarIQ index.

What is the DOI of Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression?

ScholarIQdoi

The DOI for Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression is on the source record.

What is the PMID of Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression?

ScholarIQpmid

The PMID for Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression is on the source record.

What is the OpenAlex record for Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression?

ScholarIQopenalex

The OpenAlex for Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial